October 02, 2004

Vioxx Recall Affects Arthritis Sufferers, Debate Over Osteoporosis Drugs

"A day after the popular arthritis drug Vioxx was yanked from the market because of safety concerns, doctors, patients and insurance companies were busy trying to figure out the next step."

"As women search beyond hormone treatments for ways to prevent osteoporosis, a debate is raging over which of two leading drugs that slow bone loss, Fosamax and Actonel, is better."

Posted by news editor | Filed under: Arthritis